← Browse by Condition
Medical Condition
primary central nervous system lymphoma pcnsl
Total Trials
2
Recruiting Now
2
Trial Phases
Various
NCT07074470
Recruiting
Combination Regimen of Teniposide, PD-1 Monoclonal Antibody and Selinixor for Patients With Relapsed or Refractory PCNSL
Enrollment
40 pts
Location
China
Sponsor
The First Affiliated Hospital ...
NCT06946407
Recruiting
Rituximab, Methotrexate, and Tepadina Induction Followed by Etoposide and Cytarabine Consolidation in Primary Central Nervous System Lymphoma
Enrollment
41 pts
Location
China
Sponsor
FengYan Jin